← Back to Vaccine Database

Ad26.ZEBOV + MVA-BN-Filo

Viral vector (Non-replicating) vaccine · VDDBV0039

Target & Classification

EBOVEbola virus
Viral vector (Non-replicating) vaccine
Ebola; Marburg Disease
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials11

Note: 3 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT02891980 Phase 1Ebola; Marburg Disease
NCT05064956 Phase 2Ebola; Marburg Disease
NCT02543567 Phase 3Ebola; Marburg Disease
NCT04186000 Phase 2Ebola; Marburg Disease
NCT04152486 Phase 3Ebola; Marburg Disease
NCT02661464 Phase 3Ebola; Marburg Disease
NCT03929757 Phase 2Ebola; Marburg Disease
NCT02509494 Phase 3Ebola; Marburg Disease
NCT02564523 Phase 2Ebola; Marburg Disease
NCT02598388 Phase 2Ebola; Marburg Disease
NCT02876328 Phase 2Ebola; Marburg Disease